Gene therapy for placental insufficiency moves toward the clinic

Gene therapy for placental insufficiency moves toward the clinic
journal in the field and provides all-inclusive access to the critical pillars of human gene therapy: research, methods, and clinical applications. Credit: Mary Ann Liebert, Inc., publishers

A new study identified an adenovirus gene therapy vector carrying a VEGF isoform. It can improve uterine blood flow in placental insufficiency, as reported in the peer-reviewed journal Human Gene Therapy.

Reduced uterine blood flow and lack of bioavailable VEGF due to placental insufficiency is a major cause of severe fetal growth restriction (FGR). This is untreatable and causes serious neonatal morbidity and death.

Anna David, UCL Institute for Women's Health, and colleagues tested different VEGF isoforms on from four species, including from human umbilical vein. The results support the use of the best performing VEGF isoform "in a human clinical trial for FGR caused by placental insufficiency."

"The placenta is one of the most critical and uniquely physiologically adapted structures in . The work by Dr. David and her group moves forward an important new gene therapy approach to restoring the vascular integrity of the placenta when it is impaired and thereby protecting fetal health," according to Editor-in-Chief of Human Gene Therapy Terence R. Flotte, MD, Celia and Isaac Haidak Professor of Medical Education and Dean, Provost, and Executive Deputy Chancellor, University of Massachusetts Medical School.


Explore further

Gene therapy startup to increase AAV gene therapy efficiency

More information: Carlo Rossi et al, Comparison of Efficiency and Function of Vascular Endothelial Growth Factor Adenovirus Vectors in Endothelial Cells for Gene Therapy of Placental Insufficiency, Human Gene Therapy (2020). DOI: 10.1089/hum.2020.006
Journal information: Human Gene Therapy

Citation: Gene therapy for placental insufficiency moves toward the clinic (2020, December 16) retrieved 19 September 2021 from https://medicalxpress.com/news/2020-12-gene-therapy-placental-insufficiency-clinic.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
4 shares

Feedback to editors